David S. Barlow

David S. Barlow has a diverse work experience in the healthcare industry. David S. currently serves as the Chair and CEO of Psy Therapeutics, Inc since October 2016. Prior to this, they were the Chair of the Board of Trustees at McLean Hospital, a leading psychiatric hospital, from 2008 until March 2018. David S. has also held executive positions as Chairman and CEO at Black Diamond Capital, LLC from 2008 to 2016 and at Molecular Insight Pharmaceuticals, Inc. from 2000 to 2008. David's earlier roles include President of Pharmaceuticals at Sepracor, Inc. from 1992 to 1999, VP of Global Marketing at Armour Pharmaceuticals, and manager positions at Pfizer and ARES-Serono Group, Inc. David S. has a strong background in leadership and strategic planning within the pharmaceutical industry.

David S. Barlow completed their Bachelor of Arts degree at Bates College between 1975 and 1979. David S. then proceeded to pursue their Master of Business Administration at Stanford University Graduate School of Business from 1983 to 1985.